Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN ETEXILATE vs DABRAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABIGATRAN ETEXILATE vs DABRAFENIB: Safety Overview

Metric DABIGATRAN ETEXILATE DABRAFENIB
Total FAERS Reports 37,091 19,305
Deaths Reported 5,806 4,165
Death Rate 15.7% 21.6%
Hospitalizations 21,235 5,325
Average Patient Age 74.4 yrs 58.3 yrs
% Female Patients 45.8% 48.0%
FDA Approval Date Aug 12, 2024 Mar 16, 2023
Manufacturer Apotex Corp. Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription